Clominorex

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Vanished user 0x8cSXE0x6 (talk | contribs) at 22:54, 28 August 2014. The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Clominorex
Clinical data
ATC code
  • none
Identifiers
  • (RS)-5-(4-chlorophenyl)-4,5-dihydro-1,3-oxazol-2-amine
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ChEMBL
Chemical and physical data
FormulaC9H9ClN2O
Molar mass196.63 g/mol g·mol−1
3D model (JSmol)
  • Clc1ccc(cc1)C2O\C(=N/C2)N
  • InChI=1S/C9H9ClN2O/c10-7-3-1-6(2-4-7)8-5-12-9(11)13-8/h1-4,8H,5H2,(H2,11,12) checkY
  • Key:HAHOPPGVHWVBRR-UHFFFAOYSA-N checkY
  (verify)

Clominorex is a centrally acting sympathomimetic which is related to other drugs such as aminorex and pemoline. It was developed as an appetite suppressant by McNeil Laboratories in the 1950s.[1]

See also

References

  1. ^ US Patent 3278382 - 2-amino-5-aryloxazoline compositions and methods of using same


Template:Catecholaminergics